Pasithea Therapeutics Corp. (KTTA)
NASDAQ · Manufacturing · Pharmaceutical preparations
KTTA price, last 12 months
Key stats
- Previous close
- $0.5109
- Open
- $0.5200
- Day range
- $0.4652 – $0.5252
- 52-week range
- $0.2810 – $2.06
- Volume
- 344.9K
- Avg volume (20 days)
- 1.8M
- Market cap
- $17.4M
Performance
Technicals and fundamentals
About Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. The disorders covered includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module). The Company has reportable segment, which is the business of research and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $17.4M